
USFDA APPLICATION NUMBER - 21356 / DOSAGE - TABLET;ORAL - 250MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| TENOFOVIR DISOPROXIL FUMARATE(UNII: OTT9J7900I) (TENOFOVIR ANHYDROUS - UNII:W4HFE001U5) | TENOFOVIR DISOPROXIL FUMARATE | 300mg |
Inactive Ingredients
| Ingredient Name | A-S Medication Solutions | REMEDYREPACK INC. | Apotex Corp. | American Health Packaging | Teva Pharmaceuticals USA, Inc. |
|---|---|---|---|---|---|
| ALUMINUM OXIDE(LMI26O6933) | |||||
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |||||
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |||||
| CROSPOVIDONE, UNSPECIFIED(2S7830E561) | |||||
| FD&C BLUE NO. 2(L06K8R7DQK) | |||||
| FD&C RED NO. 40(WZB9127XOA) | |||||
| HYPROMELLOSE 2910 (15 MPA.S)(36SFW2JZ0W) | |||||
| HYPROMELLOSE 2910 (15000 MPA.S)(288VBX44JC) | |||||
| INDIGOTINDISULFONATE SODIUM(D3741U8K7L) | |||||
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |||||
| MAGNESIUM STEARATE(70097M6I30) | |||||
| MANNITOL(3OWL53L36A) | |||||
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |||||
| POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A) | |||||
| POLYVINYL ALCOHOL, UNSPECIFIED(532B59J990) | |||||
| POVIDONE K30(U725QWY32X) | |||||
| SILICON DIOXIDE(ETJ7Z6XBU4) | |||||
| STARCH, CORN(O8232NY3SJ) | |||||
| TALC(7SEV7J4R1U) | |||||
| TITANIUM DIOXIDE(15FIX9V2JP) | |||||
| TRIACETIN(XHX3C3X673) |